AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


AJPH First Look, published online ahead of print Jun 2, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
AJPH.2003.034249v1
95/7/1117    most recent
Right arrow Submit a response
Right arrow purchase articles
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Get other permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Desvarieux, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Desvarieux, M.
Related Collections
Right arrow Epidemiology
Right arrow Ethics
Right arrow Global Health
Right arrow Health Policy
Right arrow HIV/AIDS
Right arrow Human Rights
July 2005, Vol 95, No. 7 | American Journal of Public Health 1117-1122
© 2005 American Public Health Association
DOI: 10.2105/AJPH.2003.034249


HEALTH POLICY AND ETHICS

Antiretroviral Therapy in Resource-Poor Countries: Illusions and Realities

Moïse Desvarieux, MD, PhD, Roland Landman, MD, Bernard Liautaud, MD, Pierre-Marie Girard, MD, PhD for the INTREPIDE Initiative In Global Health

Moïse Desvarieux is with the Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY. Roland Landman is with the Service de Maladies Infectieuses, Centre Hospitalier Universitaire, Bichat Claude Bernard, Université de Paris, Paris, France, and the Institut de Médecine et d’Épidémiologie Appliquée (IMEA), Paris. Bernard Liautaud is with the Hôspital de Jour en Maladies Infectieuses, Centre Hospitalier Universitaire de Fort-de-France, Fort-de-France, Martinique, and Groupe Haitien d’Études du Sarcome de Kaposi et des Infections Opportunistes, Port-au-Prince, Haiti. Pierre-Marie Girard is with the Service de Maladies Infectieuses et Tropicales, Centre Hospitalier Universitaire de Saint-Antoine, Université de Paris, Paris, and the Institut de Médecine et d’Épidémiologie Appliquée, Paris.

Correspondence: Requests for reprints should be sent to Moïse Desvarieux, MD, PhD, Department of Epidemiology, Mailman School of Public Health, 722 W 168th St, New York, NY 10032 (e-mail: md108{at}columbia.edu).

The prospects for antiretroviral therapy in resource-poor settings have changed recently and considerably with the availability of generic drugs, the drastic price reduction of brand-name drugs, and the simplification of treatment. However, such cost reductions, although allowing the implementation of large-scale donor programs, have yet to render treatment accessible and possible in the general population.

Successfully providing HIV treatment in high-prevalence/high-caseload countries may require that we redefine the problem as a public health mass therapy program rather than a multiplication of clinical situations. The public health goal cannot simply be the reduction of morbidity and mortality for those treated but must be the reduction in morbidity and mortality for the many, that is, at a population level.




This article has been cited by other articles:


Home page
HypertensionHome page
V. Perkovic, R. Huxley, Y. Wu, D. Prabhakaran, and S. MacMahon
The Burden of Blood Pressure-Related Disease: A Neglected Priority for Global Health
Hypertension, December 1, 2007; 50(6): 991 - 997.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Public Health Association